HER2 Support Group Forums - View Single Post - FDA reviews new data on risks of erythropoiesis-stimulating agents

News · 01-06-2008, 09:41 PM

The U.S. Food and Drug Administration (FDA) is reviewing new data from two studies that provide further evidence of the risks of anemia drugs known as erythropoiesis-stimulating agents, or ESAs.

More...

01-06-2008, 09:41 PM	#1
News Senior Member Join Date: Oct 2007 Posts: 20,138	FDA reviews new data on risks of erythropoiesis-stimulating agents The U.S. Food and Drug Administration (FDA) is reviewing new data from two studies that provide further evidence of the risks of anemia drugs known as erythropoiesis-stimulating agents, or ESAs. More...